2 weeks on semaglutide STARTING MY JOURNEY *week 1* // First injection, side effects, new appetite + work outs Semaglutide Weight Loss Program |

For patients pursuing compounded semaglutide therapy, understanding your personal tolerability profileincluding potential genetic factors influencing GLP-1 pathway responsivenesscan help you and your provider design a schedule that maximizes therapeutic benefit while minimizing side effects

This alteration in digestion can aid with long-term weight management

Understanding the correct zones and rotation strategy helps patients achieve better results from their compounded semaglutide therapy

These supplements are available for immediate purchase to further support your efforts in a safe and effective manner

LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist in people with type 2 diabetes: a phase 1b, multicentre, double-blind, placebo-controlled, randomised, multiple-ascending dose trial Multi-receptor agonists that target the glucagon, glucose-dependent insulinotropic polypeptide (GIP), and glucagon-like peptide 1 (GLP-1) receptors may improve outcomes in type 2 diabetes because this condition is linked to hyperglycemia and obesity